Joseph LaSala

Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI.

SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ.

Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ.

SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ.

Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ.

SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ.

Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI.

Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI.